← Leaderboards
Alessandro Fatatis
Drexel University
$4,109,770
Attributed
$4,999,384
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $804.2K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,999,384 · 3
By mechanism
R01$4,999,384 · 3
Top collaborators
- Olimpia Meucci5 shared
Others in their field
Top investigators on “Neoplastic Cell”
- David Heimbrook · Leidos Biomedical Research, Inc.$139,710,838
- Gregory H Reaman · National Childhood Cancer Foundation$31,993,642
- Bruce W Stillman · Cold Spring Harbor Laboratory$25,455,900
- Ralph Parchment · Leidos Biomedical Research, Inc.$25,266,647
- Andrea Califano · Columbia University Health Sciences$22,374,316
- Wendell A Lim · University Of California, San Francisco$22,334,734
Research focus
Neoplastic CellCellsAffectReceptorMolecularLesionNeoplasm MetastasisTargeted TreatmentAnimal ModelStructurePre-ClinicalBoneChemokineRegulationCancer CellTumorCell SurvivalGenesExperimental StudyReceptor ExpressionPlayPathway InteractionsSignal TransductionMetastatic To
Grant awards (14)
Interleukin-1beta and AR-negative tumor cells in metastatic castrate-resistant prostate cancer$804,195
R01 · FY2025 · CA · contact PI
Interleukin-1beta and AR-negative tumor cells in metastatic castrate-resistant prostate cancer$370,047
R01 · FY2024 · CA · contact PI
Interleukin-1beta and AR-negative tumor cells in metastatic castrate-resistant prostate cancer$381,733
R01 · FY2023 · CA · contact PI
Interleukin-1beta and AR-negative tumor cells in metastatic castrate-resistant prostate cancer$389,523
R01 · FY2022 · CA · contact PI
Role of CX3CR1 in breast cancer metastasis$357,994
R01 · FY2020 · CA · contact PI
Role of CX3CR1 in breast cancer metastasis$347,253
R01 · FY2019 · CA · contact PI
Role of CX3CR1 in breast cancer metastasis$357,994
R01 · FY2018 · CA · contact PI
Role of CX3CR1 in breast cancer metastasis$357,994
R01 · FY2017 · CA · contact PI
Role of CX3CR1 in breast cancer metastasis$357,994
R01 · FY2016 · CA · contact PI
Role of intracellular sphingolipids in calcium signaling$239,594
R01 · FY2007 · GM · contact PI
Role of intracellular sphingolipids in calcium signaling$246,750
R01 · FY2006 · GM · contact PI
Role of intracellular sphingolipids in calcium signaling$252,689
R01 · FY2005 · GM
Role of intracellular sphingolipids in calcium signaling$252,689
R01 · FY2004 · GM
Intracellular sphingolipids in calcium signaling$282,935
R01 · FY2003 · GM